QUADRIDOX INC.

Durham, NC · Medtech · Private

X-ray diffraction imaging (XRDI) scanner for automated pathology specimen analysis

Grants
$2.7M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$8.0M
2 awards · Homeland Security
#83 of 4531 in medtech
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · Development and evaluation of a combined X-ray transmission and diffraction imaging system for pathology$875,347
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · Development and evaluation of a combined X-ray transmission and diffraction imaging system for pathology$887,595
Federal contractDepartment of Homeland Security · Low False Alarm, High Throughput Hybrid Ct+ X-ray Diffraction Imaging Eds Project$5,680,621
Federal grantDepartment of Health and Human Services · Phase II · Development and evaluation of a combined X-ray transmission and diffraction imaging system for pathology$923,685
Federal contractDepartment of Homeland Security · Tabletop Threat Resolution Using Transmitted And Diffracted X-rays Lrbaa Award$2,346,460
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
80ViewRay, Inc.$8.2M$69M
81Aethlon Medical, Inc.$8.1M$22M
82LIFEWARE LABS LLC$8.1M—
83QUADRIDOX INC.$8.0M—
84Personal Genome Diagnostics Inc.$7.9M$198M
85TAO TREASURES, LLC$7.7M—
86OASIS DIAGNOSTICS CORPORATION$7.7M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Method For Capture Of Small-angle Scatter Over Wide Fields Of Viewapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.